RT Journal Article
SR Electronic
T1 Biotech Venture Capital
JF The Journal of Private Equity
FD Institutional Investor Journals
SP 85
OP 95
DO 10.3905/jpe.2008.707205
VO 11
IS 3
A1 Geoff Meyerson
A1 Ameya Agge
YR 2008
UL https://pm-research.com/content/11/3/85.abstract
AB There are only a few dozen top life science venture capital (VC) funds yet no formal study to our knowledge has evaluated what differentiates the firms or investing styles. We attempt to explain how the top life science venture capital investors evaluate investing opportunities in private biotechnology companies. While this article does not attempt to teach the proper way to invest, since clearly there are as many different styles as there are venture firms, the authors hope to shed some light on how some of the best biotechnology investors approach companies and investment decisions. The results suggest that there is a link between a style of investing and the people's backgrounds at these firms. Furthermore, there is some loose correlation to the investing style to the returns enjoyed. Lastly, a few myths about the industry are debunked.TOPICS: Private equity, manager selection, quantitative methods, style investing